Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

PET/CT in cancer of unknown primary / Nagabhushan Seshadri, Chinnamani Eswar, editors.

Contributor(s): Eswar, Chinnamani,, editor literario | Seshadri, Nagabhushan,, editor literario
Material type: materialTypeLabelE-bookSeries: (Clinicians' guides to radionuclide hybrid imaging. PET/CT, 2367-2439).Publisher: Cham, Switzerland : Springer, [2017]Copyright date: 2017Description: 1 recurso en línea : ilustraciones (algunas a color).ISBN: 3319564242; 9783319564241.Subject: Etiología médicaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Foreword; Preface; Acknowledgements; Contents; Contributors; 1: Cancer of Unknown Primary (CUP); 1.1 Introduction; 1.2 Epidemiology; 1.3 Clinical Presentation/Signs and Symptoms; 1.4 Diagnosis and Staging Procedures/Investigations; 1.5 Prognosis; References; 2: An Overview of the Pathology of Cancer of Unknown Primary; 2.1 Introduction; 2.2 Immunohistochemistry; 2.3 Molecular Diagnosis; 2.4 Subsets; References; 3: An Overview of the Management of Cancer of Unknown Primary; 3.1 Introduction; 3.2 Surgical; 3.3 Chemotherapy; 3.4 Radiotherapy; 3.5 Supportive Therapies.
3.6 Management of CUP Patients Who Do Not Fall into Any Specific SubsetReferences; 4: Radiological Imaging in Cancer of Unknown Primary; 4.1 Introduction; 4.2 Ultrasound; 4.3 Computed Tomography (CT); 4.4 MRI; 4.5 Radionuclide Bone Scan; 4.6 Limitations of Anatomical Imaging; 4.7 Terminology; 4.8 Multimodality Imaging and Multidisciplinary Team (MDT) Approach; 4.9 Role of Imaging in Investigations and Management; 4.10 Goals of a Standard CUP Workup; 4.11 Biopsy and Histology: Important Considerations; 4.12 Pearls and Pitfalls; References.
5: 18F-FDG and Non-FDG PET Radiopharmaceuticals5.1 Introduction; 5.2 PET Radiopharmaceuticals; 5.2.1 18F-FDG; 5.2.2 Non-FDG Radiopharmaceuticals; References; 6: Cancer of Unknown Primary: Role of FDG PET/CT; 6.1 Introduction; 6.2 Evidence for the Use of PET/CT in CUP; 6.3 PET/CT in Response Assessment; 6.4 PET/CT in Radiotherapy Planning; 6.5 Stand-Alone PET Versus Combined PET/CT; 6.6 PET/CT Protocols; 6.7 Limitations; 6.7.1 False Positives; 6.7.2 False Negatives; 6.8 Management Impact and Cost-Effectiveness; 6.9 Future Directions; 6.10 Recommendations; References.
7.15 Case 157.15.1 Clinical Details; Index.
7: Pictorial Atlas: Cancer of Unknown Primary7.1 Case 1; 7.1.1 Clinical Details; 7.2 Case 2; 7.2.1 Clinical Details; 7.3 Case 3; 7.3.1 Clinical Details; 7.4 Case 4; 7.4.1 Clinical Details; 7.5 Case 5; 7.5.1 Clinical Details; 7.6 Case 6; 7.6.1 Clinical Details; 7.7 Case 7; 7.7.1 Clinical Details; 7.8 Case 8; 7.8.1 Clinical Details; 7.9 Case 9; 7.9.1 Clinical Details; 7.10 Case 10; 7.10.1 Clinical Details; 7.11 Case 11; 7.11.1 Clinical Details; 7.12 Case 12; 7.12.1 Clinical Details; 7.13 Case 13; 7.13.1 Clinical Details; 7.14 Case 14; 7.14.1 Clinical Details.
Abstract: This pocket book offers a rapid and concise overview of the utility of PET/CT in the management of patients with cancer of unknown primary (CUP). Readers will gain an appreciation of the unique information provided by PET/CT on the molecular and metabolic changes associated with CUP, which can occur in the absence of corresponding anatomical alterations. Characteristic imaging appearances are documented with the aid of a series of teaching cases that serve to illustrate the potential improvements in patient management that may be achieved through early use of PET/CT in the diagnostic pathway. In addition, the relation of the clinical and pathological background to imaging is explained. The book is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for all clinicians, nuclear medicine physicians, radiologists, radiographers, and nurses who routinely work in multidisciplinary teams involved in the management of these patients.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC268.48 P483 2017 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20023826
Total holds: 0

SpringerLink

Incluye referencias bibliográficas e índice

Foreword; Preface; Acknowledgements; Contents; Contributors; 1: Cancer of Unknown Primary (CUP); 1.1 Introduction; 1.2 Epidemiology; 1.3 Clinical Presentation/Signs and Symptoms; 1.4 Diagnosis and Staging Procedures/Investigations; 1.5 Prognosis; References; 2: An Overview of the Pathology of Cancer of Unknown Primary; 2.1 Introduction; 2.2 Immunohistochemistry; 2.3 Molecular Diagnosis; 2.4 Subsets; References; 3: An Overview of the Management of Cancer of Unknown Primary; 3.1 Introduction; 3.2 Surgical; 3.3 Chemotherapy; 3.4 Radiotherapy; 3.5 Supportive Therapies.

3.6 Management of CUP Patients Who Do Not Fall into Any Specific SubsetReferences; 4: Radiological Imaging in Cancer of Unknown Primary; 4.1 Introduction; 4.2 Ultrasound; 4.3 Computed Tomography (CT); 4.4 MRI; 4.5 Radionuclide Bone Scan; 4.6 Limitations of Anatomical Imaging; 4.7 Terminology; 4.8 Multimodality Imaging and Multidisciplinary Team (MDT) Approach; 4.9 Role of Imaging in Investigations and Management; 4.10 Goals of a Standard CUP Workup; 4.11 Biopsy and Histology: Important Considerations; 4.12 Pearls and Pitfalls; References.

5: 18F-FDG and Non-FDG PET Radiopharmaceuticals5.1 Introduction; 5.2 PET Radiopharmaceuticals; 5.2.1 18F-FDG; 5.2.2 Non-FDG Radiopharmaceuticals; References; 6: Cancer of Unknown Primary: Role of FDG PET/CT; 6.1 Introduction; 6.2 Evidence for the Use of PET/CT in CUP; 6.3 PET/CT in Response Assessment; 6.4 PET/CT in Radiotherapy Planning; 6.5 Stand-Alone PET Versus Combined PET/CT; 6.6 PET/CT Protocols; 6.7 Limitations; 6.7.1 False Positives; 6.7.2 False Negatives; 6.8 Management Impact and Cost-Effectiveness; 6.9 Future Directions; 6.10 Recommendations; References.

7.15 Case 157.15.1 Clinical Details; Index.

7: Pictorial Atlas: Cancer of Unknown Primary7.1 Case 1; 7.1.1 Clinical Details; 7.2 Case 2; 7.2.1 Clinical Details; 7.3 Case 3; 7.3.1 Clinical Details; 7.4 Case 4; 7.4.1 Clinical Details; 7.5 Case 5; 7.5.1 Clinical Details; 7.6 Case 6; 7.6.1 Clinical Details; 7.7 Case 7; 7.7.1 Clinical Details; 7.8 Case 8; 7.8.1 Clinical Details; 7.9 Case 9; 7.9.1 Clinical Details; 7.10 Case 10; 7.10.1 Clinical Details; 7.11 Case 11; 7.11.1 Clinical Details; 7.12 Case 12; 7.12.1 Clinical Details; 7.13 Case 13; 7.13.1 Clinical Details; 7.14 Case 14; 7.14.1 Clinical Details.

This pocket book offers a rapid and concise overview of the utility of PET/CT in the management of patients with cancer of unknown primary (CUP). Readers will gain an appreciation of the unique information provided by PET/CT on the molecular and metabolic changes associated with CUP, which can occur in the absence of corresponding anatomical alterations. Characteristic imaging appearances are documented with the aid of a series of teaching cases that serve to illustrate the potential improvements in patient management that may be achieved through early use of PET/CT in the diagnostic pathway. In addition, the relation of the clinical and pathological background to imaging is explained. The book is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for all clinicians, nuclear medicine physicians, radiologists, radiographers, and nurses who routinely work in multidisciplinary teams involved in the management of these patients.

There are no comments on this title.

to post a comment.
Share